Follow this preprint
Multi-omics investigation on the prognostic and predictive factors in metastatic breast cancer using data from Phase III ribociclib clinical trials: A statistical and machine learning analysis plan
Thibaud Coroller, Berkman Sahiner, Anup Amatya, Alexej Gossmann, Konstantinos Karagiannis, Ravi K. Samala, Luis Santana-Quintero, Nadia Solovieff, Craig Wang, Laleh Amiri-Kordestani, Qian Cao, Kenny H. Cha, Rosane Charlab Orbach, Frank H. Cross Jr., Tingting Hu, Ruihao Huang, Jeffrey Kraft, Peter Krusche, Yutong Li, Zheng Li, Ilya Mazo, Conor Moloney, Rahul Paul, Jason Plawinski, Susan Schnakenberg, Paolo Serra, Sean Smith, Chi Song, Fei Su, Sajanth Subramaniam, Mohit Tiwari, Colin Vechery, Xin Xiong, Juan Pablo Zarate, Jonathan Ziegler, Hao Zhu, Arunava Chakravartty, Qi Liu, David Ohlssen, Nicholas Petrick, Julie A. Schneider, Mark Walderhaug, Emmanuel Zuber
doi: https://doi.org/10.1101/2023.08.30.23294367
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Thibaud Coroller
1Novartis Pharmaceutical Company, USA
Berkman Sahiner
2Center for Devices and Radiological Health, U.S. Food & Drug Administration, USA
Anup Amatya
3Center for Drug Evaluation and Research, U.S. Food & Drug Administration, USA
Alexej Gossmann
2Center for Devices and Radiological Health, U.S. Food & Drug Administration, USA
Konstantinos Karagiannis
4Center for Biologics Evaluation and Research, U.S. Food & Drug Administration, USA
Ravi K. Samala
2Center for Devices and Radiological Health, U.S. Food & Drug Administration, USA
Luis Santana-Quintero
4Center for Biologics Evaluation and Research, U.S. Food & Drug Administration, USA
Nadia Solovieff
1Novartis Pharmaceutical Company, USA
Craig Wang
5Novartis Pharma AG, Switzerland
Laleh Amiri-Kordestani
6Office of Oncologic Drugs, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, USA
Qian Cao
2Center for Devices and Radiological Health, U.S. Food & Drug Administration, USA
Kenny H. Cha
2Center for Devices and Radiological Health, U.S. Food & Drug Administration, USA
Rosane Charlab Orbach
3Center for Drug Evaluation and Research, U.S. Food & Drug Administration, USA
Frank H. Cross Jr.
3Center for Drug Evaluation and Research, U.S. Food & Drug Administration, USA
Tingting Hu
2Center for Devices and Radiological Health, U.S. Food & Drug Administration, USA
Ruihao Huang
3Center for Drug Evaluation and Research, U.S. Food & Drug Administration, USA
Jeffrey Kraft
3Center for Drug Evaluation and Research, U.S. Food & Drug Administration, USA
Peter Krusche
5Novartis Pharma AG, Switzerland
Yutong Li
1Novartis Pharmaceutical Company, USA
Zheng Li
1Novartis Pharmaceutical Company, USA
Ilya Mazo
4Center for Biologics Evaluation and Research, U.S. Food & Drug Administration, USA
Conor Moloney
5Novartis Pharma AG, Switzerland
Rahul Paul
4Center for Biologics Evaluation and Research, U.S. Food & Drug Administration, USA
Jason Plawinski
5Novartis Pharma AG, Switzerland
Susan Schnakenberg
1Novartis Pharmaceutical Company, USA
Paolo Serra
1Novartis Pharmaceutical Company, USA
Sean Smith
4Center for Biologics Evaluation and Research, U.S. Food & Drug Administration, USA
Chi Song
3Center for Drug Evaluation and Research, U.S. Food & Drug Administration, USA
Fei Su
1Novartis Pharmaceutical Company, USA
Sajanth Subramaniam
5Novartis Pharma AG, Switzerland
Mohit Tiwari
3Center for Drug Evaluation and Research, U.S. Food & Drug Administration, USA
Colin Vechery
1Novartis Pharmaceutical Company, USA
Xin Xiong
2Center for Devices and Radiological Health, U.S. Food & Drug Administration, USA
Juan Pablo Zarate
1Novartis Pharmaceutical Company, USA
Jonathan Ziegler
5Novartis Pharma AG, Switzerland
Hao Zhu
3Center for Drug Evaluation and Research, U.S. Food & Drug Administration, USA
Arunava Chakravartty
1Novartis Pharmaceutical Company, USA
Qi Liu
3Center for Drug Evaluation and Research, U.S. Food & Drug Administration, USA
David Ohlssen
1Novartis Pharmaceutical Company, USA
Nicholas Petrick
2Center for Devices and Radiological Health, U.S. Food & Drug Administration, USA
Julie A. Schneider
7Oncology Center of Excellence, U.S. Food & Drug Administration, USA
Mark Walderhaug
4Center for Biologics Evaluation and Research, U.S. Food & Drug Administration, USA
Emmanuel Zuber
5Novartis Pharma AG, Switzerland

Posted August 31, 2023.
Multi-omics investigation on the prognostic and predictive factors in metastatic breast cancer using data from Phase III ribociclib clinical trials: A statistical and machine learning analysis plan
Thibaud Coroller, Berkman Sahiner, Anup Amatya, Alexej Gossmann, Konstantinos Karagiannis, Ravi K. Samala, Luis Santana-Quintero, Nadia Solovieff, Craig Wang, Laleh Amiri-Kordestani, Qian Cao, Kenny H. Cha, Rosane Charlab Orbach, Frank H. Cross Jr., Tingting Hu, Ruihao Huang, Jeffrey Kraft, Peter Krusche, Yutong Li, Zheng Li, Ilya Mazo, Conor Moloney, Rahul Paul, Jason Plawinski, Susan Schnakenberg, Paolo Serra, Sean Smith, Chi Song, Fei Su, Sajanth Subramaniam, Mohit Tiwari, Colin Vechery, Xin Xiong, Juan Pablo Zarate, Jonathan Ziegler, Hao Zhu, Arunava Chakravartty, Qi Liu, David Ohlssen, Nicholas Petrick, Julie A. Schneider, Mark Walderhaug, Emmanuel Zuber
medRxiv 2023.08.30.23294367; doi: https://doi.org/10.1101/2023.08.30.23294367
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Subject Areas
- Addiction Medicine (409)
- Allergy and Immunology (722)
- Anesthesia (214)
- Cardiovascular Medicine (3057)
- Dermatology (258)
- Emergency Medicine (458)
- Epidemiology (12988)
- Forensic Medicine (13)
- Gastroenterology (855)
- Genetic and Genomic Medicine (4794)
- Geriatric Medicine (442)
- Health Economics (748)
- Health Informatics (3041)
- Health Policy (1098)
- Hematology (406)
- HIV/AIDS (954)
- Medical Education (452)
- Medical Ethics (119)
- Nephrology (495)
- Neurology (4568)
- Nursing (243)
- Nutrition (675)
- Oncology (2370)
- Ophthalmology (670)
- Orthopedics (266)
- Otolaryngology (332)
- Pain Medicine (298)
- Palliative Medicine (86)
- Pathology (514)
- Pediatrics (1234)
- Primary Care Research (516)
- Public and Global Health (7151)
- Radiology and Imaging (1590)
- Respiratory Medicine (941)
- Rheumatology (457)
- Sports Medicine (398)
- Surgery (506)
- Toxicology (64)
- Transplantation (218)
- Urology (188)